Timo Schinköthe, MD, PhD

Timo Schinköthe, MD, PhD is the Managing Director and Founder of CANKADO GmbH in Ottobrunn. His research focuses on integrating digital health and AI in clinical trials, balancing the rapid evolution of digital applications with the long evaluation periods of clinical studies. He leads and contributes to projects like PreCycle, AdaptCycle, and CINDERELLA, which involve AI in patient empowerment, ECG readings, and breast cancer surgery outcomes across multiple countries. Additionally, he works on AI for predicting critical events in patients with chronic disease through the OMCAT project.